Skip to main content

View full-text article in PMC

. 2008 Jan 30;3(1):e1501. doi: 10.1371/journal.pone.0001501

Table 1. Anti-HA Titer.

		Intramuscular		Intranasal
Clade	Vaccine (Dose)^a	VN/1203/2004^b	Indo/05/2005	VN/1203/2004	Indo/05/2005
Clade 1-Vietnam
	VLP (3 ug)	200,000 ^c	12,500	200,000	12,500
	VLP (600 ng)	25,000	25,000	12,500	25,000
	rHA (3 ug)	6,400	12,500	200	<100
	rHA (600 ng)	800	3,200	<100	<100
Clade 2-Indonesia	VLP (3 ug)	12,500	200,000	400,000	2,000,000
	VLP (600 ng)	25,000	200,000	25,000	200,000
	rHA (3 ug)	3,200	12,500	<100	400
	rHA (600 ng)	1,600	6,400	<100	400
	Mock	<100	<100	<100	<100

^a

Dose based upon HA content

^b

Isolate from which the HA was used.

^c

Anti-HA GMT titer.